Elite Pharmaceuticals Launches Generic Pain Medication
Company Announcements

Elite Pharmaceuticals Launches Generic Pain Medication

The latest announcement is out from Elite Pharmaceuticals ( (ELTP) ).

Elite Pharmaceuticals, Inc. has announced the commercial launch of its generic version of Tylenol® with Codeine in various dosages, marking a significant step in the company’s niche generic product offerings. The medication is intended for the management of mild to moderate pain where an opioid is appropriate, and alternatives are inadequate, boasting sales of approximately $47 million in the past year. With its facilities in Northvale, NJ, Elite Pharmaceuticals continues to develop and manufacture controlled-release oral dose products, contributing to the competitive pharmaceutical market.

See more data about ELTP stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskElite Pharmaceuticals’ Generic Adderall® Approved in Israel
TipRanks Auto-Generated NewsdeskElite Pharmaceuticals Unveils Generic Methotrexate Tablets
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App